Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers — RES  

Volume Deficiency of the Midface Clinical Trial

Official title: A Randomized, Split-face Clinical Study on Comparative Ultrasound Analysis of Two Hyaluronic Acid Fillers for Midface Correction

Status Completed

Clinical Trial Summary

To assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound

Clinical Trial Description

This is a randomized, split-face, subject-blinded, comparative study to assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound.

This study is designed to enroll and randomize approximately 15 subjects in a 1:1 ratio of treatment to Restylane Contour or Juvederm Voluma. All subjects are to have midface volume loss and contour deficiency.

Eligible subjects are randomized to receive treatment were injected by the Treating Investigator at Baseline. The method of injection is at the discretion of the Treating Investigator. A sufficient amount of product is injected to achieve optimal correction of the midface, in the opinion of the Treating Investigator and subject.

At the 4-week visit, after all study procedures for the visit are completed, treated subjects have the option of receiving a touch-up treatment to achieve optimal aesthetic improvement. At the 6-month, 9-month, and 12-month visits, similar study procedures are performed. ;

Related Conditions & MeSH terms

• Volume Deficiency of the Midface

• NCT number: NCT05622851
• Study type: Interventional
• Source: Galderma R&D
• Status: Completed
• Phase: N/A
• Start date: July 12, 2022
• Completion date: December 6, 2023